Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD as compared with placebo in patients with mild AD dementia
Critère d'inclusion
- Alzheimer’s Disease with Dementia